Use of Surface Electromyography as a Tools to Predict Upper Extremity Recovery Function After Stroke
Launched by UNIVERSITAS PADJADJARAN · Aug 24, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how a special tool called surface electromyography (sEMG) can help predict how well a person will recover movement in their arm after having a stroke. The researchers want to see if the measurements taken by sEMG can give them useful information about a patient's potential for upper extremity recovery, specifically for those who have weakness in one arm due to a stroke.
To participate in this study, individuals must be at least 18 years old and currently hospitalized due to upper arm weakness from a stroke that has been confirmed by imaging tests like a CT scan or MRI. However, those with cognitive impairments, serious medical issues, or other injuries that affect arm movement will not be eligible. If you join the trial, you can expect to undergo evaluations using sEMG to track your recovery progress. This research aims to improve understanding of stroke recovery and potentially help tailor rehabilitation efforts for better outcomes.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Patients who are hospitalized with upper extremity weakness due to stroke on the same side which confirmed with computed tomography (CT) scan or structural magnetic resonance imaging (MRI), in the acute phase
- • 2. Men and women aged more than 18 years old
- • 3. Willing to participate
- Exclusion Criteria:
- • 1. Cognitive impairment (MoCA-Ina score less than 26)
- • 2. Impaired consciousness (GCS score less than 15)
- • 3. Unstable medical conditions at time of hospitalization
- • 4. Patients with pacemaker
- • 5. Having other injury or dysfunction in the impaired side of upper extremity that caused restrictions on the range of joint movement and muscle weakness, such as fractures, periarthritis, or moderate-severe pain
- • 6. Diagnosis of other neurological disease or disorders in addition to stroke (e.g., traumatic brain injury, neuropathy or radiculopathy)
- • 7. Get treated in isolation room
- • 8. Hypersensitivity to gel electrodes
About Universitas Padjadjaran
Universitas Padjadjaran, a prestigious academic institution in Indonesia, is dedicated to advancing medical research and clinical trials that contribute to the improvement of healthcare outcomes. With a strong emphasis on interdisciplinary collaboration and innovation, the university harnesses its extensive resources and expertise to conduct rigorous studies aimed at addressing pressing health challenges. Through its commitment to ethical research practices and community engagement, Universitas Padjadjaran plays a pivotal role in fostering evidence-based medicine and enhancing the quality of life for diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bandung, West Java, Indonesia
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported